WELAB BARCELONA

Analysis of formulations

The analysis of drug formulations used in preclinical studies is needed to ensure appropriate administration regarding solubility and/or stability and to evaluate the homogeneity and stability of the formulation to cover the expected  conditions during preparation, storage, dosing, and shipment.

Methodology

We quickly develop and validate LC/MS or HPLC/UV methods for the analysis of drug content in preclinical formulations (solutions or suspensions) of small molecules under GLP. Common vehicles are methyl cellulose for in vivo studies and DMSO for in vitro studies. The methods are usually carried out under GLP compliance, although simplified studies may also be done.

Turnaround time: 3 weeks

We are proud to announce that Welab is partner of this new EU funded project.

In collaboration with 12 partners from 6 countries, Welab Barcelona is establishing the Antivirus Pandemic Preparedness EuropeAn pLatform (APPEAL), a European research initiative aimed at enhancing preparedness for future pandemics. This EU funded collaboration will establish a comprehensive program for the development of broad-spectrum antiviral drugs within a five year time frame ensuring drug affordability and accessibility to low income countries.
Link to the press release: https://lnkd.in/d-jmV2CS